X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and certain cancers. The company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. 

Biotechnology

X4 Pharmaceuticals

X4 Pharmaceuticals' headquarters in Cambridge, MA, United States

Mary DiBiase

Mark Baldry

David Kirske

Nour Ziyadeh

Jill Elliott

Yanping Hu

Gary Neumann

Kelly Neelon

Margo Jaffee

Patrick Breznak

Karen Dobson

Thienhuu Nguyen

Alejandra Murillo

Maryellen Babcock

Michael S. Wyzga

Gary J. Bridger

David McGirr

Françoise de Craecker

William Aliski

Murray W. Stewart

The Leadership Team at X4 Pharmaceuticals is responsible for setting the strategic direction and vision of the company. Comprising key executives such as the CEO, CFO, COO, and CSO, this team drives the development of innovative therapeutics by overseeing financial planning, operational efficiency, and scientific research initiatives, ensuring effective collaboration across all departments to advance the company’s mission of treating rare diseases through enhanced immune cell trafficking.

Leadership Team

The Clinical Operations and Quality Management team at X4 Pharmaceuticals is responsible for overseeing the strategic planning, execution, and management of clinical trials, ensuring regulatory compliance, data integrity, and patient safety. This team collaborates closely with cross-functional departments to uphold rigorous quality standards and implement best practices throughout the drug development process, ultimately facilitating the delivery of innovative therapies for rare diseases.

Clinical Operations and Quality Management

The Marketing and Commercial Strategy team at X4 Pharmaceuticals is responsible for developing and executing strategic marketing initiatives to promote the company’s novel therapeutics. This team collaborates closely with cross-functional partners to position products effectively in the market, optimize commercial operations, and drive engagement with healthcare providers and stakeholders. They also analyze market trends and oversee pipeline marketing efforts to ensure alignment with the company's goals in addressing rare diseases and improving immune cell trafficking.

Marketing and Commercial Strategy

The Finance and Accounting team at X4 Pharmaceuticals is responsible for managing the company’s financial health and ensuring compliance with accounting standards. This team oversees budgeting, financial reporting, and strategic financial planning, providing critical insights to support the development of novel therapeutics. They also work to optimize financial operations and manage resources effectively, enabling the company to focus on its mission of advancing innovative treatments for rare diseases.

Finance and Accounting

The Research and Development team at X4 Pharmaceuticals is dedicated to creating innovative therapeutic solutions that enhance immune cell trafficking for treating rare diseases. This interdisciplinary team, comprising regulatory affairs specialists, IT operations experts, and scientific researchers, collaborates to design, test, and optimize drug candidates targeting the CXCR4 pathway, ultimately advancing the company's mission to improve patient outcomes in immunodeficiencies and select cancers.

��

X4 Pharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Quality Management

Marketing and Commercial Strategy

Finance and Accounting

Research and Development

Offices

��������

X4 Pharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Quality Management

Marketing and Commercial Strategy

Finance and Accounting

Research and Development

Offices

Related companies

��